Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

CBOE Global Markets Inc (CBOE)

CBOE Global Markets Inc (CBOE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cboe and CNBC Launch Multi-Year Collaboration to Deliver Daily Live Market Coverage from Chicago Trading Floor

CHICAGO , March 31, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity derivatives, and CNBC, the recognized world leader in business...

CBOE : 281.07 (-0.44%)
How Is Cboe Global Markets’ Stock Performance Compared to Other Financial Stocks?

Cboe Global Markets holds a clear edge over peers, while analysts remain cautiously supportive of its outlook.

XLF : 49.37 (+2.09%)
CBOE : 281.07 (-0.44%)
CME : 295.35 (-0.75%)
Cboe Global Markets Announces Date of First-Quarter 2026 Earnings Release and Conference Call

CHICAGO , March 17, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity derivatives, will announce its financial results for the first...

CBOE : 281.07 (-0.44%)
Cboe Files Proposal with the SEC to Launch Near 24x5 U.S. Equities Trading

CHICAGO , March 16, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity derivatives, announced it submitted a proposal to the Securities...

CBOE : 281.07 (-0.44%)
Cboe to Launch BITVX, A New Volatility Index Based on IBIT Options

CHICAGO and BOCA RATON, Fla. , March 9, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, today announced plans to launch...

IBIT : 38.46 (+2.07%)
CBOE : 281.07 (-0.44%)
Cboe Introduces Innovative Prediction Markets Framework, Expanding Choice Beyond Yes-Or-No Outcomes

CHICAGO and BOCA RATON, Fla. , March 9, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, today announced its vision for...

CBOE : 281.07 (-0.44%)
Cboe Global Markets Reports Trading Volume for February 2026

CHICAGO , March 4, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, today reported February monthly trading volume statistics...

CBOE : 281.07 (-0.44%)
Cboe to Present at the Raymond James Institutional Investors Conference on March 2

CHICAGO , Feb. 24, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, announced today that Craig Donohue, Chief Executive...

CBOE : 281.07 (-0.44%)
Is Wall Street Bullish or Bearish on Cboe Global Markets Stock?

Although Cboe Global Markets has outperformed relative to the broader market over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.

XLF : 49.37 (+2.09%)
$SPX : 6,531.58 (+2.96%)
CBOE : 281.07 (-0.44%)
Cboe Global Markets Declares First-Quarter 2026 Dividend

CHICAGO , Feb. 13, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, today announced its Board of Directors has declared...

CBOE : 281.07 (-0.44%)

Barchart Exclusives

Apellis Pharma Skyrockets on Biogen Deal. Is It Too Late to Chase APLS Stock?
Apellis Pharma stock more than doubled as Biogen announced a $5.6 billion acquisition. But for investors looking to jump into APLS shares now, the ship has already sailed. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.